Article
Tumor DNA from tumor in situ fluid was used to track genomic status and evolutionary models of gliomas under first-line treatment
2022-04-08
Abstract excerpt
<h4>Background: </h4> Tumor DNA from tumor in situ fluid (TISF) provides a minimally invasive approach to repeatedly interrogated the glioma genome and provides an opportunity to monitor the dynamics of pressure-induced cloning for recurrence and treatment selectivity. Understanding the evolution of glioma will be of great help in clinical and scientific research of glioma. Currently, no study has explored the rec...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f55a58a4-8806-54fb-b6fe-399dc7cb7a7a
- DOI
- 10.21203/rs.3.rs-1422136/v2
